Top Abstract Purchase Related
Home
>
Node
>
Subnode

Drug therapy of hyperprolactinemia and acromegaly

Von Werder, K.; Eversmann, T.; Fahlbusch, R.; Rjosk, H.K.

Acta Medica Austriaca 5(3): 61-63

1978

ISSN/ISBN: 0303-8173
PMID: 377884
Document Number: 134726
Hyperprolactinemia can be treated medically. Thus all patients with a normal sella turcica and those patients with only slight enlargement of the sella turcica can be treated medically with the dopaminagonist bromocriptine. This treatment is also indicated in paitents with postoperative persisting hyperprolactinemia. In contrast to hyperprolactinemia medical therapy of acromegaly is still in the experimental stage, through the dopaminagonist bromocriptine induces a decrease of growth hormone levels and improvement of the disease in many patients with acromegaly.

Document emailed within 1 workday
Secure & encrypted payments

Marek, J.; Bauer, J.; Srámková, J.; Hána, V. 1986: Terguride in the treatment of hyperprolactinemia and acromegaly Casopis Lekaru Ceskych 125(4): 100-105
Felt, V.; Nedvídková, J. 1985: Use of dironyl in the treatment of acromegaly and hyperprolactinemia Vnitrni Lekarstvi 31(10): 980-985
Balabolkin, M.I.; Gerasimov, G.A.; Snigireva, R.I.; Gorokhova, T.R. 1989: Effectiveness of lysenyl-forte treatment in acromegaly and hyperprolactinemia syndrome Klinicheskaia Meditsina 67(9): 89-92
Rachev, E.; Spasov, S. 1985: Modern drug treatment of hyperprolactinemia Akusherstvo i Ginekologiia 24(6): 81-84
Corenblum, B.; Donovan, L. 1993: The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia Fertility and Sterility 59(3): 671-673
Muneyyirci-Delale, O.; Goldstein, D.; Reyes, F.I. 1989: Diagnosis of stress-related hyperprolactinemia. Evaluation of the hyperprolactinemia rest test New York State Journal of Medicine 89(4): 205-208
Von Werder, K.; Fahlbusch, R.; Rjosk, H.K. 1977: Hyperprolactinemia. Pathophysiology, clinical significance, therapy Der Internist 18(10): 520-528
Rampello, L.; Nicoletti, G. 1990: The H2-antagonist therapy withdrawal syndrome: the possible role of hyperprolactinemia Medicina 10(3): 294-296
Lundin, L.; Ljunghall, S.; Wide, L.; Boström, H. 1978: Bromocriptine therapy in eleven patients with acromegaly Acta Endocrinologica. Supplementum 216: 207-216
Landgraf, R.; Landgraf-Leurs, M.M.; von Werder, K.; Scriba, P.C. 1976: Therapy of the diabetic metabolic condition in hyperprolactinemias and acromegaly Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1915-1917
Trainer, P.J. 2003: Lessons from 6 years of GH receptor antagonist therapy for acromegaly Journal of endocrinological investigation 26(10 Suppl): 44-52
Petit, A.; Piednoir, Dée.; Germain, M-Laure.; Trenque, T. 2003: Drug-induced hyperprolactinemia: a case-non-case study from the national pharmacovigilance database Therapie 58(2): 159-163
Teubner, A.; Breidert, M.; Baehring, T.; Hensen, J.; Bornstein, S.R. 1997: Clinical picture, diagnosis and therapy of acromegaly patients in Eastern and Western Germany Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 91(8): 739-745
Saie, D.J.; Sills, E.S. 2005: Hyperprolactinemia presenting with encephalomalacia-associated seizure disorder and infertility: a novel application for bromocriptine therapy in reproductive endocrinology Neuro Endocrinology Letters 26(5): 533-535
Bolanowski, M.; Bar-Andziak, E.; Kos-Kudła, B.; Krzyzanowska-Swiniarska, B.; Lewiński, A.; Łomna-Bogdanov, E.; Milewicz, A.; Sowiński, J.; Zgliczyński, W. 2008: Consensus statement of the Polish Society for Endocrinology: presurgical somatostatin analogs therapy in acromegaly Neuro Endocrinology Letters 29(1): 59-62
Ho, K.Y.; Smythe, G.A.; Compton, P.J.; Lazarus, L. 1985: Long-term bromocriptine therapy may restore the inhibitory control of prolactin release in some patients with pathological hyperprolactinemia Australian and New Zealand Journal of Medicine 15(2): 213-219
Oehme, P.; Brüschke, G.; Kluchert, K.; Krüger, U. 1970: Current problems of drug therapy. 9. Stationary and ambulatory drug therapy. 2 Das Deutsche Gesundheitswesen 25(21): 957-960
Menninger, H.; Burkhardt, H. 1983: Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents Fortschritte der Medizin 101(14): 639-645
Iimori, M. 2005: Psychotherapy and drug therapy--drug therapy within the framework of psychotherapy and psychotherapy conducted during drug therapy Seishin Shinkeigaku Zasshi 107(5): 500-505
Fujii, Y. 2001: Acute phase drug therapy and drug switching in the treatment of patients with schizophrenia Seishin Shinkeigaku Zasshi 103(12): 1030-1035